Immunologix provides cutting-edge GLP & GCP compliant laboratory capabilities focused on bioanalytical & biomarker development, validation & study sample analysis in support of biologics, cell & gene therapy (C>) and nucleic acid based therapeutics. Bioanalytical Sciences: PK assays in support of large molecule, C>, and nucleic acid-based biotherapeutics. Immunogenicity: ADA and NAb assays to support all biologic modalities, including C> and nucleic acid-based therapeutics. Cell based assays: Supporting neutralizing antibody, cell proliferation, potency, and cell-based PK assays. Biomarker Sciences: Context of use driven de novo, multiplex, and commercial kit assays. Gene & Cell Therapy: Pharmaco/cellular kinetics, PD, safety, immunogenicity, biodistribution, expansion, persistence, cytokine analysis (CRS monitoring) and phenotypic analysis. Critical Reagents: Critical reagent labeling and analytical characterization services. Our deep technical skills in ligand binding, cell-based and qPCR assays coupled with scientific consultation from our Translational Sciences team offers an integration of strategic, scientific and technical expertise that is unparalleled within our industry. This enables our team to deliver valuable scientific insights that accelerate decision-making and the overall course of drug development programs for our clients.